Back to today’s briefing

Story perspectives

FDA Approves Game-Changing Device for Rheumatoid Arthritis

9/23/2025

26 3

Summary

Story summary

The FDA approved an implantable device for rheumatoid arthritis that activates the body's inflammation regulation system.
Lynn Milam, previously treatment-resistant, joined a clinical trial; Dr. John Tesser said it could treat other autoimmune diseases.
The device is implanted near the vagus nerve to modulate immune responses; Milam's voice was affected initially but improved after a second procedure.

1 of 1

Story summary

The FDA approved an implantable device for rheumatoid arthritis that activates the body's inflammation regulation system.
Lynn Milam, previously treatment-resistant, joined a clinical trial; Dr. John Tesser said it could treat other autoimmune diseases.
The device is implanted near the vagus nerve to modulate immune responses; Milam's voice was affected initially but improved after a second procedure.